In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Recent clinical trials have shown promising results of transplanting these cells into individuals with Type 1 diabetes: ...
A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
A team led by researchers at the University of Toronto has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of ...
From the discovery of the Yamanaka factors to late-stage clinical trials, induced pluripotent stem cells have revolutionized biomedical science. For the first time, scientists reprogrammed cells from ...
As the agency evaluates the utility of human embryonic stem cells in research, scientists warn that restricting the cells ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results